Physician
Laboratory Medicine Consultants LTD
Laboratory Medicine Consultants LTD was paid $2.33M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 46% of everything it billed.
33Billing provider infoLABORATORY MEDICINE CONSULTANTS LTD
LAS VEGAS, NV 89128
LAS VEGAS, NV 89128
33aNPI1083675169assigned 03/29/2006
33bProvider typeCytopathology Physician
28Total paid$2.33M
24GClaims282,721
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cytopathology Physician providers in Nevada
Rank by total paid#1 of 8
Median peer was paid$9K
This provider vs. median250×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GRATTENDICK, MICHAEL controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,586 | $127K | |
| 2019 | 37,773 | $371K | |
| 2020 | 36,489 | $350K | |
| 2021 | 48,602 | $435K | |
| 2022 | 62,293 | $501K | |
| 2023 | 55,155 | $442K | |
| 2024incomplete | 32,823 | $105K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 46% | 50,011 | 42,977 | $1.07M |
| 88307 | 20% | 12,973 | 11,517 | $462K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.8% | 6,386 | 5,907 | $111K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.8% | 6,375 | 5,895 | $111K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.1% | 5,038 | 4,724 | $72K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.0% | 3,790 | 3,517 | $70K |
| 87660 | 2.4% | 6,040 | 5,468 | $56K | |
| 85390 | 2.0% | 14,166 | 7,735 | $47K | |
| 85060 | 1.9% | 6,690 | 5,443 | $45K | |
| 88312 | 1.5% | 3,311 | 2,484 | $35K | |
| 88189 | 1.4% | 1,166 | 996 | $33K | |
| 88304 | 1.1% | 5,797 | 5,186 | $26K |
91 more codes
| 88185 | 1.1% | 132 | $26K | |
| 85576 | 1.1% | 1,608 | $26K | |
| 87653 | 1.1% | 1,346 | $25K | |
| 88108 | <1% | 3,363 | $21K | |
| 87510 | <1% | 1,829 | $12K | |
| 87480 | <1% | 1,832 | $12K | |
| 88142 | <1% | 1,061 | $11K | |
| 88342 | <1% | 910 | $9K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,347 | $7K |
| 81513 | <1% | 1,057 | $7K | |
| 85027 | <1% | 8,495 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 17,456 | $5K |
| 88341 | <1% | 130 | $2K | |
| 88184 | <1% | 130 | $2K | |
| 80050 | General health panel | <1% | 706 | $2K |
| 87625 | <1% | 147 | $2K | |
| 87481 | <1% | 1,110 | $2K | |
| 88104 | <1% | 324 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,997 | $2K |
| 88300 | <1% | 834 | $1K | |
| 83735 | <1% | 11,319 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,483 | $1K |
| 87563 | <1% | 200 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 360 | $1K |
| 88311 | <1% | 263 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,005 | $805.37 |
| 88302 | <1% | 274 | $759.02 | |
| 88141 | <1% | 48 | $653.98 | |
| 84484 | <1% | 5,086 | $600.22 | |
| 85730 | <1% | 4,128 | $563.29 | |
| 83690 | <1% | 3,311 | $373.52 | |
| 80069 | <1% | 8,730 | $325.48 | |
| 83605 | <1% | 3,363 | $312.19 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 786 | $296.36 |
| 84703 | <1% | 3,530 | $279.93 | |
| 85610 | <1% | 4,576 | $259.05 | |
| 81001 | <1% | 5,902 | $196.48 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,557 | $181.85 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,377 | $171.26 |
| 84100 | <1% | 1,391 | $128.64 | |
| 80061 | Lipid panel | <1% | 658 | $118.82 |
| 87040 | <1% | 2,073 | $114.12 | |
| 86850 | <1% | 1,096 | $97.21 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,708 | $78.49 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 940 | $62.11 |
| 82962 | <1% | 7,532 | $60.24 | |
| 86901 | <1% | 1,356 | $50.32 | |
| 87486 | <1% | 753 | $48.90 | |
| 87581 | <1% | 752 | $48.90 | |
| 83880 | <1% | 703 | $46.32 | |
| 86900 | <1% | 1,342 | $43.68 | |
| 87511 | <1% | 67 | $37.34 | |
| 85380 | <1% | 88 | $34.75 | |
| 87077 | <1% | 576 | $33.12 | |
| 86140 | <1% | 1,372 | $29.31 | |
| 87070 | <1% | 525 | $11.76 | |
| 82550 | <1% | 568 | $10.04 | |
| 82728 | <1% | 70 | $9.30 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 128 | $6.24 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 257 | $2.80 |
| 80076 | <1% | 19 | $2.55 | |
| 85007 | <1% | 129 | $2.35 | |
| 87081 | <1% | 170 | $1.14 | |
| 86593 | <1% | 443 | $0.78 | |
| 85652 | <1% | 576 | $0.48 | |
| 82565 | 0% | 95 | $0.00 | |
| 81025 | 0% | 586 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 376 | $0.00 |
| 87186 | 0% | 230 | $0.00 | |
| 84702 | 0% | 268 | $0.00 | |
| 81002 | 0% | 233 | $0.00 | |
| 80074 | 0% | 54 | $0.00 | |
| 84439 | 0% | 43 | $0.00 | |
| 80202 | 0% | 86 | $0.00 | |
| 86705 | 0% | 60 | $0.00 | |
| 86709 | 0% | 62 | $0.00 | |
| 82570 | 0% | 16 | $0.00 | |
| 82248 | 0% | 35 | $0.00 | |
| 84520 | 0% | 75 | $0.00 | |
| 84145 | 0% | 19 | $0.00 | |
| 87210 | 0% | 14 | $0.00 | |
| 86923 | 0% | 14 | $0.00 | |
| 87340 | 0% | 317 | $0.00 | |
| 80320 | 0% | 442 | $0.00 | |
| 86803 | 0% | 303 | $0.00 | |
| 86780 | 0% | 71 | $0.00 | |
| 87807 | 0% | 14 | $0.00 | |
| 83615 | 0% | 50 | $0.00 | |
| 86141 | 0% | 80 | $0.00 | |
| 80329 | 0% | 18 | $0.00 | |
| 80047 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRATTENDICK, MICHAEL (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Laboratory Medicine Consultants LTD | Las Vegas, NV | $9.16M |
| Pathology Solutions LLC | Eatontown, NJ | $5.39M |
| Laboratory of Dermatopathology Adx, LLC | Woodbury, NY | $3.57M |
| Cascade Pathology Services, Corp | Portland, OR | $2.52M |
| Consultants in Laboratory Medicine of Greater Toledo | Toledo, OH | $2.28M |
| Greensboro Pathology, LLC | Greensboro, NC | $2.16M |
| Mark and Kambour MD PA | Miami Lakes, FL | $776K |
| Dermpath New England, LLC | Boston, MA | $643K |
| Western Pathology Consultants, LTD | Reno, NV | $554K |
| Seacoast Pathology, INC. | Exeter, NH | $392K |
| Hallmark Pathology, P.C. | Melrose, MA | $118K |
| Richard Bernert, LLC | Scottsdale, AZ | $23K |
| Mid-Atlantic Pathology Services, INC. | Sterling, VA | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.